Latest News
Jazz Pharmaceuticals plc
- New Survival Data in HER2-Positive Gastroesophageal Adenocarcinoma at ESMO 2026 - Jazz Pharmaceuticals
- Jazz Pharmaceuticals Public Limited Company Estimates – MUN:J7Z
- Jazz Pharmaceuticals: 9-Month CXO Transformation
- Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 2, 2026
- Jazz Pharmaceuticals: Ziihera And Portfolio Diversification Are Changing The Earnings Story
- Jazz Pharmaceuticals posts strong Q2 2026 resul...
- Form 144 JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY For: 11 October
- Jazz Pharmaceuticals gets Cramer backing in CNBC stock call segment
- Cramer's lightning round: 'I'm going to say yes to Jazz Pharmaceuticals'
- Jazz Pharmaceuticals (NASDAQ:JAZZ): An Undervalued Biopharma Value Stock
- Form 4 Jazz Pharmaceuticals plc For: 7 October
- Jazz Pharmaceuticals - See A Seizure — The Immortal Awards — LBB - LBB
Headlines from the last 30 days, linking to the original publishers. See all market news →